Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -39.74%794.39M | -24.41%1.05B | -17.06%877.37M | -27.83%1.14B | -25.28%1.32B | 46.00%1.39B | 49.07%1.06B | 96.07%1.58B | 153.92%1.76B | 17.18%952.6M |
Transactional financial assets | 403.98%403.84M | ---- | -65.22%202.1M | ---- | -86.49%80.13M | ---- | 457.39%581.12M | 74.91%210.43M | 811.90%593.28M | ---- |
Notes receivable and accounts receivable | -7.50%1.43B | 10.17%1.5B | 2.42%1.54B | 4.85%1.45B | 42.92%1.54B | 38.27%1.36B | 76.37%1.5B | 65.36%1.39B | 40.65%1.08B | 27.05%982.6M |
-Notes receivable | -38.27%133.35M | 32.01%179.1M | -50.34%87.71M | -42.84%117.75M | 16.61%216.02M | -12.77%135.67M | 76.46%176.62M | 32.17%206M | -12.48%185.25M | -36.34%155.53M |
-Accounts receivable | -2.49%1.29B | 7.74%1.32B | 9.45%1.45B | 13.18%1.34B | 48.37%1.33B | 47.87%1.22B | 76.35%1.33B | 72.95%1.18B | 60.86%895.13M | 56.31%827.07M |
Other receivables (including interest and dividends) | 27.39%15.59M | -3.72%11.17M | -6.05%14.74M | -31.65%11.47M | -40.85%12.24M | -23.52%11.61M | -24.81%15.69M | 19.78%16.78M | 22.40%20.69M | -11.08%15.18M |
-Other receivable | ---- | -3.72%11.17M | ---- | -31.65%11.47M | ---- | -23.52%11.61M | ---- | 19.78%16.78M | ---- | -11.08%15.18M |
Contractual assets | 536.01%5.55M | 522.19%5.43M | --4.33M | --1.87M | --872.38K | --872.38K | ---- | ---- | ---- | ---- |
Advance payment | 62.28%218.11M | 52.65%182.03M | 38.79%168.74M | 42.57%151.96M | 14.58%134.4M | 1.85%119.25M | 9.36%121.57M | -12.12%106.59M | -2.37%117.3M | -6.46%117.09M |
Inventories | 14.18%1.84B | 12.15%1.74B | 3.29%1.73B | 7.09%1.75B | 0.71%1.61B | 3.99%1.56B | 3.87%1.67B | 14.01%1.64B | 20.12%1.6B | 24.45%1.5B |
Receivable financing | -23.71%7.09M | -39.75%5.98M | -43.68%2.97M | -74.69%4.51M | -33.53%9.29M | 253.74%9.93M | --5.27M | --17.83M | --13.98M | --2.81M |
Other current assets | 344.84%313.2M | 351.74%285.03M | 568.83%237.55M | 169.39%262.78M | -12.65%70.41M | -9.79%63.1M | -55.65%35.52M | 99.59%97.55M | 15.49%80.61M | 24.61%69.94M |
Adjustment items of current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- |
Total current assets | 5.12%5.03B | 6.04%4.78B | -4.36%4.77B | -5.41%4.78B | -9.29%4.78B | 24.03%4.51B | 43.12%4.99B | 49.28%5.06B | 71.86%5.27B | 21.68%3.64B |
Non Current assets | ||||||||||
Other debt investment | -9.05%633.47M | -6.14%639.24M | 33.07%634.73M | 110.47%680.91M | --696.46M | --681.04M | --477M | --323.51M | ---- | ---- |
Other equity investment | -15.92%148.9M | -5.21%148.9M | 12.54%177.09M | 12.54%177.09M | 12.54%177.09M | -0.17%157.09M | 25.38%157.36M | 25.38%157.36M | -7.38%157.36M | 25.38%157.36M |
Other non-current financial assets | 0.12%80.92M | 0.05%80.86M | 0.07%80.92M | 0.07%80.92M | -0.04%80.82M | -0.04%80.82M | --80.86M | --80.86M | --80.86M | --80.86M |
Investment real estate | -6.50%34.85M | -6.92%35.3M | -6.37%36.32M | -6.27%36.98M | -7.08%37.27M | -6.97%37.93M | -6.36%38.79M | -6.26%39.45M | -6.50%40.11M | -6.06%40.77M |
Fixed assets | ---- | 7.75%1.91B | ---- | 21.35%1.84B | ---- | 34.94%1.77B | ---- | 64.21%1.51B | ---- | 69.12%1.31B |
Constru in process | ---- | 6.12%91.53M | ---- | -23.40%108.62M | ---- | -22.76%86.25M | ---- | -24.20%141.79M | ---- | -48.71%111.67M |
Intangible assets | -0.54%228.55M | -1.27%224.44M | -2.93%222.74M | -1.20%224.92M | -3.44%229.78M | -1.99%227.32M | -2.96%229.45M | 7.36%227.66M | 20.34%237.96M | 28.48%231.92M |
Goodwill | -2.87%137.93M | -2.87%137.93M | 0.00%142M | 0.00%142M | -0.01%142M | 22.16%142M | 22.16%142M | 22.16%142M | 22.90%142.02M | 3.63%116.25M |
Long deferred expense | -14.62%15.07M | 9.77%17.8M | -40.59%16.62M | 124.38%20.86M | 93.44%17.65M | 61.33%16.21M | 287.04%27.97M | 25.32%9.3M | -78.41%9.12M | 16.03%10.05M |
Deferred tax assets | 115.21%328.65M | 107.49%287.88M | 146.00%282.26M | 122.95%236.65M | 73.64%152.71M | 80.81%138.75M | 66.76%114.74M | 76.92%106.14M | 12.06%87.95M | 0.04%76.74M |
Usufruct assets | -12.05%25.83M | 29.18%33.09M | 95.80%29.92M | 116.75%32.74M | 120.95%29.36M | 79.94%25.61M | 31.90%15.28M | 24.19%15.1M | 70.35%13.29M | 65.14%14.24M |
Other non current assets | -17.84%231.79M | -13.96%233.44M | -26.29%231.24M | -30.81%223.14M | -23.90%282.12M | -33.68%271.32M | -35.19%313.72M | -28.55%322.5M | 26.01%370.73M | 51.00%409.1M |
Adjustment items of non current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
Total non current assets | 4.04%4.06B | 6.25%4.02B | 14.51%3.97B | 23.22%3.96B | 40.39%3.9B | 40.71%3.79B | 47.01%3.47B | 44.65%3.21B | 32.62%2.78B | 41.43%2.69B |
Adjustment items of total assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- |
Total assets | 4.63%9.08B | 6.14%8.81B | 3.37%8.74B | 5.71%8.74B | 7.86%8.68B | 31.12%8.3B | 44.69%8.46B | 47.45%8.27B | 55.93%8.05B | 29.36%6.33B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -43.94%198.04M | -33.50%135.11M | -58.04%183.1M | -34.92%248.15M | -15.35%353.29M | -51.67%203.18M | 2.09%436.34M | -7.07%381.27M | 98.75%417.38M | 189.91%420.37M |
Notes payable and accounts payable | 3.15%1.07B | 15.46%1.07B | 11.12%1.07B | 8.71%1.12B | 19.83%1.04B | 24.63%927.32M | 23.97%967.32M | 43.75%1.03B | 41.69%867.46M | 20.53%744.08M |
-Notes payable | 71.14%367.59M | 15.54%287.42M | 15.11%349.48M | -7.10%276.34M | -2.63%214.79M | 9.75%248.77M | 50.13%303.6M | 60.10%297.47M | 18.93%220.61M | 36.66%226.67M |
-Accounts payable | -14.55%704.67M | 15.44%783.3M | 9.30%725.45M | 15.09%848.31M | 27.49%824.68M | 31.14%678.55M | 14.82%663.72M | 38.06%737.07M | 51.58%646.85M | 14.60%517.41M |
Contract liabilities | -15.00%152.08M | 4.14%144.93M | 80.80%206.53M | -10.54%126.39M | -10.70%178.91M | -34.93%139.17M | -30.12%114.24M | 36.73%141.28M | 155.31%200.34M | 234.74%213.87M |
Salaries payable | 43.18%196.94M | 47.99%185.93M | 34.10%79.73M | 20.97%61.93M | 33.92%137.55M | 22.74%125.64M | 3.98%59.46M | 14.00%51.19M | 31.14%102.72M | 35.02%102.36M |
Taxs payable | 39.10%62.47M | 209.95%69.96M | 84.50%87.15M | 467.06%205.5M | 34.49%44.91M | -43.18%22.57M | 332.13%47.24M | 237.03%36.24M | 164.25%33.39M | 68.61%39.72M |
Other payable (including interest and dividends) | 71.94%24.16M | 39.30%15.64M | -13.82%8.6M | 487.82%72.07M | -39.76%14.05M | -6.60%11.23M | -1.68%9.98M | 14.04%12.26M | -62.40%23.32M | 138.56%12.02M |
-Dividend payable | ---- | ---- | ---- | --53.1M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | 39.30%15.64M | ---- | 54.71%18.97M | ---- | -6.60%11.23M | ---- | 14.04%12.26M | ---- | 138.99%12.02M |
Non current liabilities due within one year | -30.85%8.94M | -25.98%10.99M | 34.40%9.83M | 141.52%15.02M | 72.56%12.93M | -14.33%14.85M | -55.64%7.32M | -62.38%6.22M | 47.22%7.49M | 318.11%17.33M |
Other current liabilities | -56.27%43.99M | -59.84%48.57M | -79.70%37.02M | -63.00%52.95M | -16.11%100.59M | -18.37%120.94M | 2,281.23%182.38M | 2,669.26%143.13M | 1,008.90%119.91M | 4,942.53%148.16M |
Total current liabilities | -6.53%1.76B | 7.48%1.68B | -7.53%1.69B | 5.57%1.91B | 6.19%1.88B | -7.83%1.56B | 23.80%1.82B | 36.68%1.81B | 65.67%1.77B | 81.07%1.7B |
Current liabilities | ||||||||||
Bonds payable | -2.50%1.34B | -2.50%1.32B | 4.20%1.4B | 4.19%1.38B | 4.22%1.37B | 5,196,320.09%1.36B | --1.34B | --1.33B | --1.31B | --26.08K |
Estimate liabilities | 24.73%44.08M | 12.18%39.68M | 35.77%23.24M | 56.34%30.38M | 64.93%35.34M | 78.94%35.37M | 74.51%17.11M | 81.29%19.43M | 92.86%21.43M | --19.77M |
Deferred tax liabilities | -21.49%75.64M | -2.44%96.1M | 10.10%104.6M | -2.29%95.15M | 39.73%96.34M | 42.40%98.5M | 86.75%95M | 92.06%97.38M | 43.59%68.95M | 45.87%69.18M |
Long term deferred income | 27.73%145.55M | -3.62%109M | 5.25%114.52M | -0.03%109.01M | 1.98%113.95M | 5.62%113.1M | -3.92%108.81M | -5.14%109.04M | -4.98%111.73M | -9.43%107.08M |
Lease liabilities | -3.05%12.95M | 144.20%18.85M | 173.96%16.95M | 73.93%14.59M | 150.06%13.36M | 22.11%7.72M | 52.77%6.19M | 57.46%8.39M | 194.78%5.34M | 51.36%6.32M |
Total non current liabilities | -0.37%1.62B | -0.99%1.59B | 5.64%1.66B | 4.51%1.63B | 7.03%1.63B | 454.17%1.61B | 485.82%1.57B | 475.20%1.56B | 446.24%1.52B | 71.05%290.49M |
Total liabilities | -3.67%3.38B | 3.18%3.28B | -1.44%3.35B | 5.08%3.54B | 6.58%3.51B | 59.66%3.17B | 94.89%3.39B | 111.47%3.37B | 144.30%3.29B | 79.53%1.99B |
Shareholders equity | ||||||||||
Paid-in capital | 1.70%454.92M | 1.70%454.92M | 0.25%448.44M | 0.25%448.44M | 0.00%447.3M | 0.29%447.3M | 0.29%447.3M | 0.29%447.3M | 0.29%447.3M | 0.23%446.02M |
Other equity instruments | -6.78%210.81M | -6.08%212.41M | -1.11%226.15M | -1.12%226.15M | -11.39%226.15M | --226.15M | --228.68M | --228.7M | --255.21M | ---- |
Capital reserve funds | 17.24%2.57B | 15.51%2.47B | 8.92%2.27B | 10.38%2.25B | 10.11%2.19B | 12.37%2.14B | 14.87%2.08B | 13.55%2.04B | 12.29%1.99B | 10.97%1.91B |
Surplus reserve funds | 78.64%200.03M | 78.64%200.03M | 17.64%111.97M | 17.64%111.97M | 17.63%111.97M | 17.63%111.97M | 13.01%95.18M | 13.01%95.18M | 13.02%95.19M | 13.02%95.19M |
Retained profit | 20.60%2.46B | 21.08%2.32B | 28.72%2.34B | 23.20%2.09B | 30.44%2.04B | 28.95%1.91B | 33.49%1.82B | 30.76%1.69B | 30.91%1.57B | 20.50%1.48B |
Less:Treasury stock | 84.71%300.28M | 342.33%265.01M | --249.43M | --212.55M | --162.57M | --59.91M | ---- | ---- | ---- | ---- |
Other composite income | -68.87%9.6M | -68.74%9.64M | 0.28%31.14M | -1.48%30.6M | -0.56%30.83M | -0.61%30.83M | 334.14%31.05M | 338.62%31.06M | 337.80%31M | 338.04%31.02M |
Specific reserves | 76.24%2.37M | 70.80%1.86M | 25.37%1.82M | 159.46%1.6M | 437.31%1.34M | 907.36%1.09M | 1,226.21%1.45M | 286.84%617.19K | 170.40%250.21K | 349.39%107.99K |
Attributable parent company shareholders equity adjustment items | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- |
Shareholders equity without minority interests | 14.74%5.61B | 12.30%5.4B | 10.10%5.19B | 8.99%4.94B | 11.49%4.89B | 21.47%4.81B | 26.72%4.71B | 25.01%4.53B | 25.08%4.38B | 13.68%3.96B |
Minority interests | -66.92%93.74M | -59.32%126.14M | -39.76%214.04M | -29.04%259.48M | -23.66%283.33M | -17.86%310.05M | -8.46%355.32M | -5.75%365.67M | 20.37%371.12M | 26.28%377.44M |
Total shareholder equity | 10.27%5.7B | 7.97%5.53B | 6.60%5.4B | 6.15%5.2B | 8.75%5.17B | 18.05%5.12B | 23.39%5.07B | 22.04%4.9B | 24.70%4.76B | 14.68%4.34B |
Total liabilityies and equity | 4.63%9.08B | 6.14%8.81B | 3.37%8.74B | 5.71%8.74B | 7.86%8.68B | 31.12%8.3B | 44.69%8.46B | 47.45%8.27B | 55.93%8.05B | 29.36%6.33B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | -- | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.